More recently, interactions between HIF-1 and β-catenin identified in a variety of cancers under hypoxic conditions have been found to promote tumor cell protection, progression, and metastatic potential [59], [60], [61], amplifying the interest in Wnt signaling as a therapeutic target for cancer [62], [63], [64]. The gene discussed is HIF1A; the disease is neoplasm.